USPTO serial 86694500
ESLATAM
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAKHDOOM, SAIMA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ESLATAM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Bevilacqua, Esquire
MICHAEL J. BEVILACQUA, ESQUIRE Wilmer Cutler Pickering Hale Dorr60 State St Ste 25Boston, MA 02109-1816UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations and substances, namely, analgesics; anti-infectives; anti-inflammatories; pharmaceutical products and preparations, namely, products for the treatment of epilepsy, neuropathic pain, and bipolar disorder; anti-epileptic drugs; pharmaceutical products, preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations and substances for the prevention and treatment of attention deficit disorder and attention deficit hyperactivity disorder; pharmaceutical preparations and substances for the prevention and treatment of eating disorders; pharmaceutical preparations for use in respiratory therapy and for the treatment of lung, nasal and other respiratory system conditions and disorders, chronic obstructive pulmonary disease, asthma and allergies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 29, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 26, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 1, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 1, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 11, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 26, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2015 | NWAP | NEW APPLICATION ENTERED | — |